Cancer immunotherapy | The PD-L1 pathway
3:21
PD-L1/PD-1 pathway: a security checkpoint
5:11
Unleashing the T-cell army | Cancer immunotherapy at Roche
2:50
How do ALK-inhibitors work in ALK-positive lung cancer?
7:17
Multiple sclerosis | Understanding the roles of B cells
1:42
HPV Self-Collection
18:31
Moving Science Podcast: Episode 4. Part 1/2
57:33
Perspectives Programmes Webcast 2025
9:25